Peroxisome proliferator-activated receptor γ agonist pioglitazone inhibits β-catenin-mediated glioma cell growth and invasion

Molecular and Cellular Biochemistry

Volumn 349, Issue 1-2, 2011, Pages 1-10

  Wan, Zhengqiang ^a,b   Shi, Wei ^b   Shao, Bai ^b   Shi, Jinlong ^b   Shen, Aiguo ^b   Ma, Yuyuan ^a   Chen, Jian ^b   Lan, Qing ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Catenin; Glioma; Growth; Invasion; Pioglitazone; PPAR

Indexed keywords

BETA CATENIN; PIOGLITAZONE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PPAR GAMMA; RNA INTERFERENCE; THIAZOLIDINEDIONES;

EID: 78650936018     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0637-9     Document Type: Article

References (37)

1. H Ohgaki P Kleihues 2005 Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 64 479 489 1:CAS:528:DC%2BD2MXlvVSgsbg%3D 15977639 (Pubitemid 40781150)
2. LM DeAngelis 2001 Brain tumors N Engl J Med 344 114 123 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D 10.1056/NEJM200101113440207 11150363 (Pubitemid 32052502)
3. SA Kliewer HE Xu MH Lambert TM Willson 2001 Peroxisome proliferator-activated receptors: from genes to physiology Recent Prog Horm Res 56 239 263 1:CAS:528:DC%2BD3MXitV2lu7k%3D 10.1210/rp.56.1.239 11237216 (Pubitemid 36068063)
4. KL Houseknecht BM Cole PJ Steele 2002 Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review Domest Anim Endocrinol 22 1 23 1:CAS:528:DC%2BD38XitFWmtLo%3D 10.1016/S0739-7240(01)00117-5 11900961 (Pubitemid 34438654)
5. C Grommes GE Landreth MT Heneka 2004 Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists Lancet Oncol 5 419 429 1:CAS:528:DC%2BD2cXlsVSitrc%3D 10.1016/S1470-2045(04)01509-8 15231248 (Pubitemid 38878045)
6. P Tontonoz S Singer BM Forman P Sarraf JA Fletcher CD Fletcher RP Brun E Mueller S Altiok H Oppenheim RM Evans BM Spiegelman 1997 Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor Proc Natl Acad Sci USA 94 237 241 1:CAS:528:DyaK2sXktVGjtA%3D%3D 10.1073/pnas.94.1.237 8990192 (Pubitemid 27027193)
7. E Mueller P Sarraf P Tontonoz RM Evans KJ Martin M Zhang C Fletcher S Singer BM Spiegelman 1998 Terminal differentiation of human breast cancer through PPAR gamma Mol Cell 1 465 470 1:CAS:528:DyaK1cXhtlyhurk%3D 10.1016/S1097-2765(00)80047-7 9660931 (Pubitemid 128378895)
8. T Kubota K Koshizuka EA Williamson H Asou JW Said S Holden I Miyoshi HP Koeffler 1998 Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo Cancer Res 58 3344 3352 1:CAS:528:DyaK1cXltFyisrw%3D 9699665 (Pubitemid 28371075)
9. P Sarraf E Mueller D Jones FJ King DJ DeAngelo JB Partridge SA Holden LB Chen S Singer C Fletcher BM Spiegelman 1998 Differentiation and reversal of malignant changes in colon cancer through PPARgamma Nat Med 4 1046 1052 1:CAS:528:DyaK1cXlvFGju7c%3D 10.1038/2030 9734398 (Pubitemid 28417337)
10. H Sato S Ishihara K Kawashima N Moriyama H Suetsugu H Kazumori T Okuyama MA Rumi R Fukuda N Nagasue Y Kinoshita 2000 Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists Br J Cancer 83 1394 1400 1:CAS:528: DC%2BD3cXos12gsrk%3D 10.1054/bjoc.2000.1457 11044367
11. T Zander JA Kraus C Grommes U Schlegel D Feinstein T Klockgether G Landreth J Koenigsknecht MT Heneka 2002 Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma J Neurochem 81 1052 1060 1:CAS:528:DC%2BD38XksV2hs7o%3D 10.1046/j.1471-4159.2002.00899.x 12065618 (Pubitemid 34809288)
12. K Berge KJ Tronstad EN Flindt TH Rasmussen L Madsen K Kristiansen RK Berge 2001 Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways Carcinogenesis 22 1747 1755 1:CAS:528:DC%2BD3MXosV2msL8%3D 10.1093/carcin/22.11.1747 11698335 (Pubitemid 33064838)
13. A Wodarz R Nusse 1998 Mechanisms of Wnt signaling in development Annu Rev Cell Dev Biol 14 59 88 1:CAS:528:DyaK1cXnvFyju74%3D 10.1146/annurev.cellbio.14. 1.59 9891778 (Pubitemid 29001449)
14. RT Cox C Kirkpatrick M Peifer 1996 Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis J Cell Biol 134 133 148 1:CAS:528:DyaK28XktVCqur8%3D 10.1083/jcb.134.1.133 8698810 (Pubitemid 26231526)
15. J Huelsken R Vogel V Brinkmann B Erdmann C Birchmeier W Birchmeier 2000 Requirement for beta-catenin in anterior-posterior axis formation in mice J Cell Biol 148 567 578 1:CAS:528:DC%2BD3cXhtFSqt7s%3D 10.1083/jcb.148.3.567 10662781
16. NA Wong M Pignatelli 2002 Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 160 389 401 1:CAS:528:DC%2BD38XitVClu74%3D 10.1016/S0002-9440(10)64856-0 11839557
17. M Verras Z Sun 2006 Roles and regulation of Wnt signaling and beta-catenin in prostate cancer Cancer Lett 237 22 32 1:CAS:528: DC%2BD28XkvVyms7g%3D 10.1016/j.canlet.2005.06.004 16023783
18. A Valster NL Tran M Nakada ME Berens AY Chan M Symons 2005 Cell migration and invasion assays Methods 37 208 215 1:CAS:528:DC%2BD2MXht1SrtbbE 10.1016/j.ymeth.2005.08.001 16288884 (Pubitemid 41587431)
19. JS Rao PA Steck S Mohanam WG Stetler-Stevenson LA Liotta R Sawaya 1993 Elevated levels of M(r) 92, 000 type IV collagenase in human brain tumors Cancer Res 53 2208 2211 1:STN:280:DyaK3s3ltFCgug%3D%3D 8485704 (Pubitemid 23156800)
20. PA Forsyth H Wong TD Laing NB Rewcastle DG Morris H Muzik KJ Leco RN Johnston PM Brasher G Sutherland DR Edwards 1999 Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas Br J Cancer 79 1828 1835 1:STN:280:DyaK1M3itFWnsw%3D%3D 10.1038/sj.bjc.6690291 10206300 (Pubitemid 29132312)
21. L Mariani C Beaudry WS McDonough DB Hoelzinger T Demuth KR Ross T Berens SW Coons G Watts JM Trent JS Wei A Giese ME Berens 2001 Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis J Neurooncol 53 161 176 1:STN:280: DC%2BD3MnmvFyruw%3D%3D 10.1023/A:1012253317934 11716068 (Pubitemid 33034689)
22. Liu X, Wang L, Zhao S, Ji X, Luo Y, Ling F Beta-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastoma cells. Med Oncol
23. T Ohta A Elnemr M Yamamoto I Ninomiya S Fushida G Nishimura T Fujimura H Kitagawa M Kayahara K Shimizu S Yi K Miwa 2002 Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta- catenin system in a human pancreatic cancer cell line, BxPC-3 Int J Oncol 21 37 42 1:CAS:528:DC%2BD38Xlt1KhtL4%3D 12063547
24. RH Giles JH van Es H Clevers 2003 Caught up in a Wnt storm: Wnt signaling in cancer Biochim Biophys Acta 1653 1 24 1:CAS:528:DC%2BD3sXktFWmur8%3D 12781368 (Pubitemid 36627817)
25. EA Jansson A Are G Greicius IC Kuo D Kelly V Arulampalam S Pettersson 2005 The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells Proc Natl Acad Sci USA 102 1460 1465 1:CAS:528:DC%2BD2MXhs1Kltrk%3D 10.1073/pnas.0405928102 15665104 (Pubitemid 40209192)
26. RR Henry AM Lincoff S Mudaliar M Rabbia C Chognot M Herz 2009 Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study Lancet 374 126 135 1:CAS:528:DC%2BD1MXotl2ks7s%3D 10.1016/S0140-6736(09)60870-9 19515415
27. C Clar P Royle N Waugh 2009 Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis PLoS One 4 e6112 10.1371/journal.pone.0006112 19568428
28. A Giese R Bjerkvig ME Berens M Westphal 2003 Cost of migration: invasion of malignant gliomas and implications for treatment J Clin Oncol 21 1624 1636 1:STN:280:DC%2BD3s7nvFWitw%3D%3D 10.1200/JCO.2003.05.063 12697889 (Pubitemid 46594118)
29. R Coras A Holsken S Seufert J Hauke IY Eyupoglu M Reichel C Trankle FA Siebzehnrubl R Buslei I Blumcke E Hahnen 2007 The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion Mol Cancer Ther 6 1745 1754 1:CAS:528:DC%2BD2sXmsFCru7w%3D 10.1158/1535-7163.MCT-06-0763 17541035 (Pubitemid 46954051)
30. N Strakova J Ehrmann P Dzubak J Bouchal Z Kolar 2004 The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines J Pharmacol Exp Ther 309 1239 1247 1:CAS:528: DC%2BD2cXksFCntb4%3D 10.1124/jpet.103.063438 14988421 (Pubitemid 38669715)
31. F Condorelli P Salomoni S Cotteret V Cesi SM Srinivasula ES Alnemri B Calabretta 2001 Caspase cleavage enhances the apoptosis-inducing effects of BAD Mol Cell Biol 21 3025 3036 1:CAS:528:DC%2BD3MXivFOqs7Y%3D 10.1128/MCB.21.9.3025- 3036.2001 11287608 (Pubitemid 32298370)
32. JC Reed 1997 Double identity for proteins of the Bcl-2 family Nature 387 773 776 1:CAS:528:DyaK2sXktVOlsr0%3D 10.1038/42867 9194558 (Pubitemid 27270895)
33. M Moldes Y Zuo RF Morrison D Silva BH Park J Liu SR Farmer 2003 Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis Biochem J 376 607 613 1:CAS:528: DC%2BD3sXps1yqtL4%3D 10.1042/BJ20030426 12954078 (Pubitemid 38058060)
34. F Chen M Wang JP O'Connor M He T Tripathi LE Harrison 2003 Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta J Cell Biochem 90 732 744 1:CAS:528:DC%2BD3sXpt1Cnt78%3D 10.1002/jcb.10668 14587029 (Pubitemid 37392464)
35. JM Perez-Ortiz P Tranque CF Vaquero B Domingo F Molina S Calvo J Jordan V Cena J Llopis 2004 Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma J Biol Chem 279 8976 8985 1:CAS:528:DC%2BD2cXhs1Onu78%3D 10.1074/jbc.M308518200 14699130 (Pubitemid 38295959)
36. AM Lennon M Ramauge A Dessouroux M Pierre 2002 MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species J Biol Chem 277 29681 29685 1:CAS:528:DC%2BD38XmsVKitbg%3D 10.1074/jbc.M201517200 12052825
37. C Ward I Dransfield J Murray SN Farrow C Haslett AG Rossi 2002 Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism J Immunol 168 6232 6243 1:CAS:528:DC%2BD38XksFWmtLs%3D 12055237 (Pubitemid 34620043)